3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
5
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Melanoma
2
Glioma
2
Colorectal Neoplasms
2
Barrett Esophagus
2
Adenocarcinoma of Lung
2
Thyroid Nodule
1
Thyroid Neoplasms
1
Spinal Fractures
1
Smoking Cessation
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Phyllodes Tumor
1
Pancreatic Neoplasms
1
Osteoporosis
1
Nevus
1
Neoplastic Cells, Circulating
1
Multiple Pulmonary Nodules
1
Lymphoma, Follicular
1
Lung Diseases
1
Locally Advanced Pancreatic Cancer
1
Liver Cirrhosis
1
Inflammatory Bowel Diseases
1
Hypertension, Portal
1
Head and Neck Neoplasms
1
Interventions
Gemcitabine
4
Radiosurgery
2
Electroporation
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
surufatinib
1
Tomography, X-Ray Computed
1
S 1 (combination)
1
Pancreatectomy
1
Oxaliplatin
1
Leucovorin
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Fluorouracil
1
Endoscopy
1
Drug Therapy
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Locally Advanced Pancreatic Cancer
×
Diagnostic Imaging
×
Clear all
NCT06944587
2025-04-25
NORPACT-3
Oslo University Hospital
Recruiting
400 enrolled